MedTrace Logo

Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation

NCT03846830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-11-12

No results posted yet for this study

Summary

The objective for this study is to compare outcome measures from vestibular rehabilitation (VPT) delivered in a traditional method against a new device Incremental Velocity Error (IVE) that improves physiologic performance of the vestibulo-ocular reflex. Participants include active duty service members with mild traumatic brain injury (mTBI) and civilians with peripheral vestibular hypofunction. The investigators will use a clinical trial cross-over design with randomization to either the control (VPT) or experimental (IVE) group and measure vestibulo-ocular reflex function as well as subjective and functional outcomes in order to investigate the best means to improve delivery of vestibular rehabilitation.

Conditions

  • Mild Traumatic Brain Injury
  • Vestibular Neuropathy

Interventions

BEHAVIORAL

Traditional Vestibular Rehabilitation (VPT)

Standard of care, meta-analysis vetted, eye and head motion exercises to reduced morbidity associated with dizziness and imbalance.

DEVICE

Incremental Velocity Error (IVE)

A lightweight headband has electronics attached that detect head velocity and move a laser target at a fraction of the head velocity.

Sponsors & Collaborators

  • Fort Belvoir Community Hospital

    collaborator FED

  • Neuroscience Research Australia

    collaborator OTHER

  • Walter Reed National Military Medical Center

    collaborator FED

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Michael C Schubert, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2025-04-01
Completion
2025-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03846830 on ClinicalTrials.gov